Simulations Plus

$62.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.76 (-1.19%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell SLP and other stocks, options, and ETFs commission-free!

About SLP

Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. It designs and develops pharmaceutical simulation software to promote cost-effective solutions to a number of problems in pharmaceutical research and in the education of pharmacy and medical students.

CEO
Shawn M. O'Connor
Employees
137
Headquarters
Lancaster, California
Founded
1996
Market Cap
1.21B
Price-Earnings Ratio
116.44
Dividend Yield
0.38
Average Volume
245.89K
High Today
$63.71
Low Today
$62.06
Open Price
$63.25
Volume
193.40K
52 Week High
$90.92
52 Week Low
$36.15

SLP News

BenzingaApr 12

Simulations Plus: Q2 Earnings Insights

Shares of Simulations Plus (NASDAQ:SLP) moved higher after the company reported Q2 results. Quarterly Results Earnings per share increased 25.00% over the pas
BenzingaApr 12

Simulations Plus, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / April 12, 2021 / Simulations Plus, Inc. (NASDAQ:SLP) will be discussing their earnings results in their 2021 Second Quarter Earnings

SLP Earnings

$0.00
$0.07
$0.13
$0.20
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
$0.14 per share
Actual
$0.15 per share
Replay Earnings Call

You May Also Like

GNTX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure